Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.
about
The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphanAnimal models of schizophrenia: a critical reviewBlonanserin ameliorates phencyclidine-induced visual-recognition memory deficits: the complex mechanism of blonanserin action involving D₃-5-HT₂A and D₁-NMDA receptors in the mPFC.The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medicationsSimilarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: relevance to schizophreniaBehavioral and molecular evidence for psychotropic effects in L-theanine.Protective effects of silibinin and its possible mechanism of action in mice exposed to chronic unpredictable mild stressBrain in flames - animal models of psychosis: utility and limitationsRepeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.Comparative evaluation of forced swim test and tail suspension test as models of negative symptom of schizophrenia in rodents.Differential Effects of Olanzapine and Haloperidol on MK-801-induced Memory Impairment in MiceInvolvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022.Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia.Withdrawal from chronic, intermittent access to a highly palatable food induces depressive-like behavior in compulsive eating rats.Depressive behavior in the forced swim test can be induced by TRPV1 receptor activity and is dependent on NMDA receptors.Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis.Evaluation of the antipsychotic potential of Panax quinquefolium in ketamine induced experimental psychosis model in mice.Neonatal Immune Challenge with Lipopolysaccharide Triggers Long-lasting Sex- and Age-related Behavioral and Immune/Neurotrophic Alterations in Mice: Relevance to Autism Spectrum Disorders.Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice.The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis.Alteration in the plasma concentration of a DAAO inhibitor, 3-methylpyrazole-5-carboxylic acid, in the ketamine-treated rats and the influence on the pharmacokinetics of plasma D-tryptophan.Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test.Models of aspects of schizophrenia: behavioral sensitization induced by subchronic phencyclidine administration.Analysis of licking microstructure provides no evidence for a reduction in reward value following acute or sub-chronic phencyclidine administration.Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action.Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function.Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin.Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors.Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine.Effects of Subacute Administration of Co-Trimoxazole and Folic Acid on Ovarian Tissue in Adult Female Rats.Antipsychotic activity of standardized Bacopa extract against ketamine-induced experimental psychosis in mice: Evidence for the involvement of dopaminergic, serotonergic, and cholinergic systems.Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment.Opposing short- and long-term effects on muscarinic M1/4 receptor binding following chronic phencyclidine treatment.Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis.Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.Effects of administration of co-trimoxazole and folic acid on sperm quality and histological changes of testes in male rats.Is Forced Swimming Immobility a Good Endpoint for Modeling Negative Symptoms of Schizophrenia? - Study of Sub-Anesthetic Ketamine Repeated Administration Effects.Phencyclidine rapidly decreases neuronal mRNA of brain-derived neurotrophic factor.The Phosphodiesterase 10A Selective Inhibitor TAK-063 Improves Cognitive Functions Associated with Schizophrenia in Rodent Models.Exposure to enriched environments during adolescence prevents abnormal behaviours associated with histone deacetylation in phencyclidine-treated mice.
P2860
Q24670521-D46A309F-9697-4DA5-BEF2-6E35F40D72A6Q24674909-123FAF73-7335-4281-96E7-96A6DF1A3BBBQ27311205-B5A6D4AE-1830-48E6-9511-269C88605D69Q28270728-63474870-D6B9-481D-A78B-D1864FD72523Q34127175-EB621032-BF79-4FFD-BEE5-6DEB6951A126Q34210127-AEEBC19A-A90A-49AE-B198-4A1FA3D8B14FQ35597505-8D1C7B95-55A6-471E-BB75-5806EEFE99FEQ35683865-79AE8647-E4BB-4649-924F-8D7E53080CD9Q36590407-4531E58D-5D50-4FC0-8C8A-1400D77A0E1AQ36857678-0091E44D-CAF8-4D02-BB60-9B4C6AEF2F69Q37160637-77F0F56A-CD0F-44B8-A5ED-1EA9624133D7Q37172877-BC5A4F50-4B57-49F3-8DED-E8A9FBAC1B3BQ37306496-34FF2E07-AA9D-4A72-A0B6-396E58C7A345Q37602666-A33AAE75-DC24-4081-A838-DF95FFB2CC66Q37626027-86DBC0F5-A494-4765-BEBA-77BF9A838FEAQ38258215-A7796713-CF3D-4E2B-AB30-76993E1468F6Q39673251-E16F30D6-2CA1-4465-B8B0-14D0162E49B2Q40201273-A339FE76-7F81-4E6B-8305-BA7670A087D3Q40689016-72C3FC2F-21D7-435E-9EEC-F1D9E8BE9BCBQ41435708-4934CC5B-1565-4486-95F1-3BF9731FCD9FQ41995548-25823FA4-C455-4241-A91D-6FFF15EDF408Q42627702-96023498-8B51-49FE-9694-ACC3D9DFD52AQ42721752-8662DCF0-2F0C-4C3F-BBF6-147131F4E1E6Q43166544-C37D006A-4D28-45DE-AD86-477731274299Q44357525-48F2EC05-E9F9-4743-86AE-1DD690E09AD2Q44407135-B0DAC26C-C994-4AF7-930F-43DE4413BF52Q46411318-6C226DA7-4765-45C1-971E-3B51447916F8Q46446352-6BE5E121-D9B6-4C9E-A086-AF45775A792EQ46913948-8EE31275-229E-447B-8F78-61C13492B19FQ47128226-75336FDF-59DC-4735-B708-C2CFD000D6D7Q47723761-67F84C40-9AA9-413A-9043-9B19CEDF248CQ48221355-FE7E5335-4F50-46B4-AE6C-6C9C3FA5CDCFQ48251420-F8D77FA6-F48C-4FEA-9F90-B2F40A89E1D6Q48273440-A7C9B543-A6AC-4AB9-9F2B-6CCE2C4EE5E0Q48286778-70BF172A-740D-433B-AA55-F118B1228AFCQ49428026-976984C4-518A-40F9-A939-49FB24FF86E5Q50497664-19DF2D05-08A6-4A52-9E3F-CE9882D25CF7Q50655613-31FFD038-D7A6-4B9B-8138-934244F203C0Q50687731-C10E79F3-6EAA-4564-A48A-D45DBFBEA252Q50982611-199C4F68-8641-42A9-9331-9CB818AB174D
P2860
Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Enhancement of immobility in a ...... a new model of schizophrenia.
@en
Enhancement of immobility in a ...... a new model of schizophrenia.
@nl
type
label
Enhancement of immobility in a ...... a new model of schizophrenia.
@en
Enhancement of immobility in a ...... a new model of schizophrenia.
@nl
prefLabel
Enhancement of immobility in a ...... a new model of schizophrenia.
@en
Enhancement of immobility in a ...... a new model of schizophrenia.
@nl
P2093
P2860
P1476
Enhancement of immobility in a ...... a new model of schizophrenia.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1995.TB15106.X
P407
P577
1995-11-01T00:00:00Z